Rodman David Malcom — SEC Form 4 filings
SEC reporting owner CIK 1672659. 51 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers the 50 most recent of 51 filings on record, filed 2024-02-13 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 54 legs across 33 filings — 596,358 shares, $16,987,285 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 164.
- Largest priced transaction: sale of 139,245 shares @ $34.83 ($4,849,555) in Mineralys Therapeutics, Inc., filed 2026-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | 50 | — | 54 legs · 596,358 sh · $16,987,285 | 164 |
Form 4 filings — Rodman David Malcom
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $27.09 · Option exercise (M): 2,170 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 416 @ $15.44 · Sale (S): 416 @ $26.53 · Option exercise (M): 416 (derivative) @ $0 | EDGAR |
| 2026-07-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Option exercise (M): 6,349 @ $1.08 · Sale (S): 14,058 @ $27.58 · Sale (S): 6,349 @ $26.61 · Option exercise (M): 3,542 (derivative) @ $0 · +2 more | EDGAR |
| 2026-07-10 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $30.30 · Option exercise (M): 2,171 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 3,542 @ $10.20 · Sale (S): 9,890 @ $23.81 · Option exercise (M): 4,167 @ $14.25 · Option exercise (M): 417 @ $15.44 · Sale (S): 4,584 @ $25 · Option exercise (M): 3,542 (derivative) @ $0 · +2 more | EDGAR |
| 2026-06-12 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $25 · Option exercise (M): 6,349 @ $1.08 · Sale (S): 6,349 @ $23.93 · Option exercise (M): 2,170 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 417 @ $15.44 · Sale (S): 417 @ $27.55 · Option exercise (M): 417 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $29.71 · Option exercise (M): 6,348 @ $1.08 · Sale (S): 6,348 @ $29.36 · Option exercise (M): 3,541 @ $10.20 · Option exercise (M): 4,166 @ $14.25 · +5 more | EDGAR |
| 2026-04-21 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 416 @ $15.44 · Sale (S): 416 @ $31.33 · Option exercise (M): 416 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Sale (S): 14,058 @ $26.54 · Sale (S): 6,348 @ $27.66 · Option exercise (M): 6,349 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $27.38 · Option exercise (M): 2,170 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 417 @ $15.44 · Sale (S): 417 @ $25.65 · Option exercise (M): 417 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,348 @ $1.08 · Sale (S): 6,348 @ $27.37 · Option exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Sale (S): 10,726 @ $25.91 · Sale (S): 3,079 @ $27.37 · +4 more | EDGAR |
| 2026-03-10 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $26.84 · Option exercise (M): 2,171 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 38,400 @ $0 · Grant/award (A): 51,300 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 417 @ $15.44 · Sale (S): 417 @ $27.59 · Option exercise (M): 417 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,349 @ $1.08 · Sale (S): 5,828 @ $28.94 · Sale (S): 521 @ $29.64 · Option exercise (M): 3,541 @ $10.20 · Sale (S): 3,541 @ $27.33 · Option exercise (M): 4,166 @ $14.25 · +5 more | EDGAR |
| 2026-02-11 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,171 @ $16 · Sale (S): 2,171 @ $30.21 · Option exercise (M): 2,171 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 416 @ $15.44 · Sale (S): 416 @ $32.10 · Option exercise (M): 416 (derivative) @ $0 | EDGAR |
| 2026-01-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 3,542 @ $10.20 · Option exercise (M): 4,167 @ $14.25 · Sale (S): 7,709 @ $32.75 · Sale (S): 11,367 @ $32.61 · Option exercise (M): 3,542 (derivative) @ $0 · Option exercise (M): 4,167 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 2,170 @ $16 · Sale (S): 2,170 @ $33.27 · Option exercise (M): 6,348 @ $1.08 · Sale (S): 6,348 @ $32.32 · Option exercise (M): 2,170 (derivative) @ $0 · Option exercise (M): 6,348 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 10,053 @ $1.08 · Option exercise (M): 3,629 @ $15.44 · Option exercise (M): 9,347 @ $10.20 · Option exercise (M): 20,168 @ $16 · Option exercise (M): 24,193 @ $14.25 · Sale (S): 70,037 @ $35.87 · +17 more | EDGAR |
| 2025-10-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Sale (S): 10,369 @ $43.01 | EDGAR |
| 2025-09-16 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Sale (S): 9,302 @ $35.90 · Sale (S): 2,065 @ $36.47 | EDGAR |
| 2025-08-14 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,349 @ $1.08 · Sale (S): 11,365 @ $12.93 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,349 @ $1.08 · Sale (S): 11,366 @ $14.59 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,348 @ $1.08 · Sale (S): 11,366 @ $14.60 · Option exercise (M): 6,348 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Sale (S): 11,366 @ $15.29 | EDGAR |
| 2025-05-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2025-04-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,348 @ $1.08 · Sale (S): 2,966 @ $13.69 · Sale (S): 8,400 @ $14.83 · Option exercise (M): 6,348 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 1,606 @ $1.08 · Sale (S): 30,574 @ $15.00 · Sale (S): 2,791 @ $16.02 · Sale (S): 22,406 @ $16.77 · Option exercise (M): 1,606 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 6,348 @ $1.08 · Option exercise (M): 6,348 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,018 @ $0.54 · Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 5,018 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 5,017 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 5,026 @ $1.08 · Sale (S): 5,026 @ $15.00 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 5,026 (derivative) @ $0 | EDGAR |
| 2024-11-08 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 25,482 @ $1.08 · Sale (S): 25,482 @ $15.03 · Option exercise (M): 25,482 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 5,352 @ $1.08 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 5,352 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,018 @ $0.54 · Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 5,018 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 6,348 @ $1.08 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 6,348 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 525 @ $1.08 · Sale (S): 525 @ $15.00 · Option exercise (M): 525 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,018 @ $0.54 · Option exercise (M): 6,348 @ $1.08 · Option exercise (M): 5,018 (derivative) @ $0 · Option exercise (M): 6,348 (derivative) @ $0 | EDGAR |
| 2024-05-10 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 100 @ $1.08 · Sale (S): 100 @ $15 · Option exercise (M): 100 (derivative) @ $0 | EDGAR |
| 2024-04-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 6,348 @ $1.08 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 6,348 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Option exercise (M): 5,017 @ $0.54 · Option exercise (M): 6,349 @ $1.08 · Option exercise (M): 5,017 (derivative) @ $0 · Option exercise (M): 6,349 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1672659 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →